COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS
Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed indirect comparisons.
| Published in: | Рациональная фармакотерапия в кардиологии |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/109 |